Digestive disease drugs
These companies make medicines for bowel and digestive diseases such as ulcerative colitis and Crohn's disease.
+82.5%
over 1 year · S&P 500 +11.6%
Key indicators
Health
51 / 100
Fragile
Solid
Price
P/E 25
Cheap
Expensive
Up over 1 year
7 of 12
Volatility
66%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 15 companies
SYRE
+343.9%
PTGX
+54.3%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
S
Spyre Therapeutics
SYRE
40.9%
+343.9%
P
Protagonist Therapeutics
PTGX
34.5%
+54.3%
T
First Tracks Biotherapeutics
TRAX
8.9%
O
Odyssey Therapeutics
ODTX
4.1%
I
Ironwood Pharmaceuticals
IRWD
3.2%
+55.3%
A
Ardelyx
ARDX
3.1%
−48.8%
S
Shattuck Labs
STTK
2.1%
+142.2%
P
Phathom Pharmaceuticals
PHAT
1.9%
−58.5%
P
Palisade Bio
PALI
0.8%
−45.1%
A
Abeona Therapeutics
ABEO
0.6%
−51.0%
A
Abivax
ABVX
−15.3%
A
AgomAb Therapeutics
AGMB
B
Bausch Health Companies
BHC
+20.3%
E
Eupraxia Pharmaceuticals
EPRX
+23.5%
T
Takeda Pharmaceutical
TAK
+54.2%